Aim To assess endothelial nitric oxide synthase (eNOS) gene (G894T) polymorphism and nitric oxide (NO) level in hypertensive diabetic Bataknese patients. Methods A hospital-based, case control study (hypertensive and normotensive diabetic patient) was conducted. Genotyping of eNOS gene (G894T) was done using polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP). Nitric oxide was quantified by sandwich enzyme-linked immunosorbent assay (Sandwich ELISA). Results GT polymorphism and T allele were higher in the hypertensive diabetic patients, 37.5% (p=0.6) and 54% (p=0.39), respectively. Nitric oxide level tended to be lower in the hypertensive diabetic patients (88.87µmol/L) comparing to the normotensive (95.42 µmol/L (p=0.54), as well as GT and TT polymorphism type (p=0.75). Conclusion eNOS gene (G894T) polymorphism is not associated with NO level and hypertension in the diabetic Bataknese patients.
Moguib O, Raslan HM, Rasheed IA, Effat L, Mohamed N, El Serougy S, et al. Endothelial nitric oxide synthase gene (T786C and G894T) polymorphisms in Egyptian patients with type 2 diabetes. J Genet Eng Biotechnol. 2017;15:431–6.
2.
Luo Z, Jia A, Lu Z, Muhammad I, Adenrele A, Song Y. Associations of the NOS3 rs1799983 polymorphism with circulating nitric oxide and lipid levels: a systematic review and meta-analysis. Postgrad Med J. 2019;865:361–71.
3.
Zintzaras E, Kitsios G, Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension. 2006;48:700–10.
4.
Gamil S, Erdmann J, Abdalrahman IB, Mohamed AO. Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study. BMC Med Genet. 2017;18(128).
5.
Li J, Cun Y, Tang WR, Wang Y, Li SN, Ouyang HR, et al. Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China. Genet Mol Res. 2011;10:2202–12.
6.
Shankarishan P, Borah PK, Ahmed G, Mahanta J. Endothelial nitric oxide synthase gene polymorphisms and the risk of hypertension in an Indian population. Biomed Res Int. 2014;2014(793040).
7.
Niu W, Qi Y. An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PloS One. 2011;6:e24266.
8.
Shahid SM, Mahboob T. Diabetes and hypertension: correlation between glycosylated hemoglobin (HbA1c) and serum nitric oxide (NO. Aust J Basic Appl Sci. 2009;3:1323–7.
9.
Manju M, Mishra S, Toora BD. Relationship between glycosylated hemoglobin, serum nitric oxide and mean arterial blood pressure. Int J Biomed Sci. 2014;10:252–7.
10.
Ayub T, Khan SN, Ayub SG, Dar R, Andrabi KI. Reduced nitrate level in individuals with hypertension and diabetes. J Cardiovasc Dis Res. 2011;2:172–6.
11.
Simanjuntak BA. Struktur sosial dan sistem politik Batak Toba hingga 1945 (Toba Batak social structure and political system until 1945. 2006;
12.
Association AD. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:8–16.
13.
The seventh report of the joint national committee on prevention, detection, evaluation.
14.
Angeline T, Krithiga HR, Isabel W, Asirvatham AJ, Poornima A. Endothelial nitric oxide synthase gene polymorphism (G894T) and diabetes mellitus (type II) among South Indians. Oxid Med Cell Longev. 2011;2011(462607).
15.
World Health Organization. Cardiovascular Diseases. 2019;
16.
Zhu B, Si X, Gong Y, Yan G, Wang D, Qiao Y, et al. An association between the endothelial nitric oxide synthase gene G894T polymorphism and premature coronary artery disease: a metaanalysis. Oncotarget. 2017;8:77990–8.
17.
Arafa S, Abdelsalam S, El-Gilany AH, Mosaad YM, Abdel-Ghaffar A. Endothelial nitric oxide synthase Glu 298 Asp (G894T) and apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among Egyptians. Egypt Heart J. 2018;70:393–401.
18.
Moraes MP, KSF, Lagares MH, Barbosa AM, Martins JVM, Campedelli FI, et al. Polymorphism of the genes eNOS, GSTT1 and GSTM1 are significantly associated with atherosclerotic disease in hypertensive patient.
19.
Men C, Tang K, Lin G, Li J, Zhan Y. ENOS-G894T polymorphism is a risk factor for essential hypertension in China. Indian J Biochem Biophys. 2011;48:154–7.
20.
Leineweber K, Moosmang S, Paulson D. Genetics of NO deficiency. Am J Cardiol. 2017;120(8S).
21.
Lüscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527–32.
22.
Tan KC, Chow WS, Ai VH, Lam KS. Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria. Diabetes Metab Res Rev. 2002;18:71–6.
23.
Avogaro A, Albiero M, Menegazzo L, Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes care. 2011;34(Supplement 2).
24.
Cheung B. The hypertension-diabetes continuum. J Cardiovasc Pharmacol. 2010;55:333–9.
25.
Lonati C, Morganti A, Comarella L, Mancia G, Zanchetti A, Group IPERDIAS. Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study. J Hypertens. 2008;26:1801–8.
26.
World Health Organization. Indonesia. 2019;
27.
Peltzer K, Pengpid S. The prevalence and social determinants of hypertension among adults in Indonesia: a cross-sectional population-based national survey. Int J Hypertens. 2018;5610725.
28.
Bloch MJ. Worldwide prevalence of hypertension exceeds 1.3 billion. J Am Soc Hypertens. 2016;10:753–4.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
